Trial Profile
Pharmacokinetic study a fixed dose combination of olanzapine and samidorphan, in subjects with hepatic impairment compared to healthy control subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Olanzapine/samidorphan (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- 01 Oct 2018 New trial record
- 01 Sep 2018 Results published in the Clinical Pharmacology in Drug Development